Protein Kinase-Inhibitor Database: Structural Variability of and Inhibitor Interactions with the Protein Kinase P-Loop

被引:39
|
作者
Patel, Ronak Y. [1 ]
Doerksen, Robert J. [1 ,2 ]
机构
[1] Univ Mississippi, Dept Med Chem, Sch Pharm, University, MS 38677 USA
[2] Univ Mississippi, Pharmaceut Sci Res Inst, University, MS 38677 USA
基金
美国国家科学基金会;
关键词
distorted P-loop; hydrophobic motif; AGC kinase [cAMP-dependent protein kinase (PKA)/protein; kinase G/protein kinase C (PKC); kinase structure space; atom preference; conformational plasticity; LIGAND-BINDING SITES; FUNCTIONAL CLASSIFICATION; DRUG DESIGN; MOLECULAR-MECHANISM; CRYSTAL-STRUCTURE; C-ABL; RESISTANCE; IMATINIB; COMPLEX; DOMAIN;
D O I
10.1021/pr100662s
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Structure-based drug design of protein-kinase inhibitors has been facilitated by availability of an enormous number of structures in the Protein Databank (PDB), systematic analyses of which can provide insight into the factors that govern ligand-protein kinase interactions and into the conformational variability of the protein kinases. In this study, a nonredundant database containing 755 unique, curated, and annotated PDB protein kinase-inhibitor complexes (each consisting of a single protein kinase chain, a ligand, and water molecules around the ligand) was created. With this dataset, analyses were performed of protein conformational variability and interactions of ligands with 11 P-loop residues. Analysis of ligand-protein interactions included ligand atom preference, ligand-protein hydrogen bonds, and the number and position of crystallographic water molecules around important P-loop residues. Analysis of variability in the conformation of the P-loop considered backbone and side-chain dihedral angles, and solvent accessible surface area (SASA). A distorted conformation of the P-loop was observed for some of the protein kinase structures. Lower SASA was observed for the hydrophobic residue in of several members of the AGC family of protein kinases. Our systematic studies were performed amino acid-by-amino acid, which is unusual for analyses of protein kinase-inhibitor complexes.
引用
收藏
页码:4433 / 4442
页数:10
相关论文
共 50 条
  • [31] Reflectometric-based sensor arrays for the screening of kinase-inhibitor interactions and kinetic determination
    Wurster, Viola
    Fechner, Peter
    Proll, Guenther
    Pamies-Cuberos, Rebecca
    Frech, Matthias
    Baumgaertner, Jens
    Malissa, Antonia
    Marchetti-Deschmann, Martina
    Ivleva, Natalia P.
    Saal, Christoph
    Fuchs, Sebastian
    Moniot, Sebastien
    Goettsche, Anja
    Huhn, Carolin
    ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2025,
  • [32] Molecular basis for p38 protein kinase inhibitor specificity
    Lisnock, JM
    Tebben, A
    Frantz, B
    O'Neill, EA
    Croft, G
    O'Keefe, SJ
    Li, B
    Hacker, C
    de Laszlo, S
    Smith, A
    Libby, B
    Liverton, N
    Hermes, J
    LoGrasso, P
    BIOCHEMISTRY, 1998, 37 (47) : 16573 - 16581
  • [33] ROTTLERIN, A NOVEL PROTEIN-KINASE INHIBITOR
    GSCHWENDT, M
    MULLER, HJ
    KIELBASSA, K
    ZANG, R
    KITTSTEIN, W
    RINCKE, G
    MARKS, F
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 199 (01) : 93 - 98
  • [34] Butein, a specific protein tyrosine kinase inhibitor
    Yang, EB
    Zhang, K
    Cheng, LY
    Mack, P
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 245 (02) : 435 - 438
  • [35] A SPECIFIC INHIBITOR FOR TYROSINE PROTEIN-KINASE
    OGAWARA, H
    AKIYAMA, T
    ISHIDA, J
    WATANABE, SI
    SUZUKI, KI
    JOURNAL OF PHARMACOBIO-DYNAMICS, 1987, 10 (02): : S37 - S37
  • [36] A hot spot for protein kinase inhibitor sensitivity
    Bishop, AC
    CHEMISTRY & BIOLOGY, 2004, 11 (05): : 587 - 589
  • [37] Raf kinase inhibitor protein (RKIP) in cancer
    June Escara-Wilke
    Kam Yeung
    Evan T. Keller
    Cancer and Metastasis Reviews, 2012, 31 : 615 - 620
  • [38] Raf kinase inhibitor protein (RKIP) in cancer
    Escara-Wilke, June
    Yeung, Kam
    Keller, Evan T.
    CANCER AND METASTASIS REVIEWS, 2012, 31 (3-4) : 615 - 620
  • [39] IVERMECTIN - AN INHIBITOR OF PROTEIN-KINASE-C
    ELLIS, C
    NATHWANI, B
    MORRICE, N
    PARKER, P
    EVANS, FJ
    AITKEN, A
    TROPICAL MEDICINE AND PARASITOLOGY, 1986, 37 (01): : 77 - 77
  • [40] Platinum complex as a nanomolar protein kinase inhibitor
    Williams, Douglas S.
    Carroll, Patrick J.
    Meggers, Eric
    INORGANIC CHEMISTRY, 2007, 46 (08) : 2944 - 2946